Associate Director, Global Labeling Product Leader at Johnson & Johnson

Allschwil, Basel-Landschaft, Switzerland

Johnson & Johnson Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Healthcare, MedTechIndustries

Requirements

  • Leadership role partnering with Global Regulatory Leads (GRLs) and functional areas (clinical, safety, market access, commercial, medical affairs)
  • Understanding of competitors in the therapeutic area, their development plans, status, and labeling aspects
  • Knowledge of labeling guidance, trends, risk and mitigation identification, and assessment
  • Ability to lead Health Authority (HA) labeling strategy discussions and contingency plans
  • Experience in developing, revising, reviewing, agreeing, and maintaining target labeling, primary labeling (CCDS, USPI, associated patient labeling, EUPI), and derived documents
  • Capability to lead cross-functional Labeling Working Group (LWG) and strategic labeling discussions
  • Proficiency in representing global labeling in Global Regulatory teams, cross-functional teams, and governance meetings (e.g., Labeling Committee)
  • Expertise in providing strategic labeling advice for local labeling in major markets and alignment with clinical study protocols, endpoints, and Patient-Reported Outcomes (PROs)

Responsibilities

  • Drive the global labeling strategy, including understanding competitors, development plans, status, and labeling for new products
  • Partner with GRLs and functional areas to align global labeling strategy with Global Regulatory and Product Strategy
  • Lead target labeling development
  • Collaborate with functional areas to provide labeling input for clinical study protocols, ensuring alignment on endpoints and PROs with a label-as-driver approach
  • Provide strategic labeling advice for local labeling in major markets
  • Analyze competitor labeling, leverage guidance and trends to develop strategy and content, including risk and mitigation
  • Lead HA labeling strategy discussions and development of contingency labeling plans and content
  • Lead development, revision, review, agreement, and maintenance of target labeling, primary labeling (CCDS, USPI, patient labeling, EUPI), and derived documents
  • Lead cross-functional LWG and strategic labeling discussions for target and primary labeling
  • Represent global labeling in Global Regulatory teams and other cross-functional teams
  • Present at governance meetings (e.g., Labeling Committee) for endorsement
  • Provide advice and guidance on labeling content, processes, timelines, and scientific integrity
  • Coordinate resolution of labeling issues

Skills

Regulatory Affairs
Global Labeling
Product Leadership
Pharmaceutical R&D
Compliance
Regulatory Strategy
Innovative Medicine

Johnson & Johnson

Healthcare products in pharmaceuticals and devices.

About Johnson & Johnson

Johnson & Johnson operates in the healthcare sector with three main areas: pharmaceuticals, medical devices, and consumer health products. In the pharmaceuticals segment, the company develops prescription drugs for various medical conditions such as cancer and infectious diseases. The medical devices segment provides products used in surgeries and other medical procedures, while the consumer health segment offers over-the-counter products, including baby care and personal health items. Johnson & Johnson generates revenue through direct sales and partnerships, and it invests significantly in research and development to create new products that meet the needs of consumers and healthcare providers. The company stands out from competitors by emphasizing diversity, equity, and inclusion in its workplace, fostering an environment where employees can share their perspectives. Its goal is to improve patient outcomes and enhance the overall health and well-being of individuals globally.

New Brunswick, New JerseyHeadquarters
1886Year Founded
IPOCompany Stage
HealthcareIndustries
10,001+Employees

Risks

J&J faces a class action lawsuit in Australia over ineffective cold and flu medications.
Former J&J executives joining other firms could lead to increased competition.
Ongoing legal battles, like the lawsuit against Cigna, pose financial liabilities for J&J.

Differentiation

J&J operates in three segments: pharmaceuticals, medical devices, and consumer health.
The company invests heavily in R&D for innovative medical solutions and products.
J&J is committed to diversity, equity, and inclusion in its workplace culture.

Upsides

J&J's collaboration with Helsinki University Hospital focuses on value-based healthcare models.
The rise of personalized medicine offers J&J opportunities in targeted therapies.
Increased focus on digital health solutions presents expansion opportunities for J&J.

Land your dream remote job 3x faster with AI